FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES
The invention provides a conjugate comprising a biomolecule linked to a fatty acid via a linker wherein the fatty acid has the following Formula A1:wherein R1, R2, R3, n and m are defined herein. The invention also relates to uses of the fatty acids in providing said conjuage. The invention also rel...
Saved in:
Main Authors | , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
27.02.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention provides a conjugate comprising a biomolecule linked to a fatty acid via a linker wherein the fatty acid has the following Formula A1:wherein R1, R2, R3, n and m are defined herein. The invention also relates to uses of the fatty acids in providing said conjuage. The invention also relates to a method for manufacturing the conjugate of the invention such as GDF15 conjugate, and its therapeutic uses such as treatment or prevention of metabolic disorders or diseases, type 2 diabetes mellitus, obesity, pancreatitis, dyslipidemia, alcoholic and nonalcoholic fatty liver disease/steatohepatitis and other progressive liver diseases, insulin resistance, hyperinsulinemia, glucose intolerance, hyperglycemia, metabolic syndrome, hypertension, cardiovascular disease, atherosclerosis, peripheral arterial disease, stroke, heart failure, coronary heart disease, diabetic complications (including but not limited to chronic kidney disease), neuropathy, gastroparesis and other metabolic disorders. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition. |
---|---|
AbstractList | The invention provides a conjugate comprising a biomolecule linked to a fatty acid via a linker wherein the fatty acid has the following Formula A1:wherein R1, R2, R3, n and m are defined herein. The invention also relates to uses of the fatty acids in providing said conjuage. The invention also relates to a method for manufacturing the conjugate of the invention such as GDF15 conjugate, and its therapeutic uses such as treatment or prevention of metabolic disorders or diseases, type 2 diabetes mellitus, obesity, pancreatitis, dyslipidemia, alcoholic and nonalcoholic fatty liver disease/steatohepatitis and other progressive liver diseases, insulin resistance, hyperinsulinemia, glucose intolerance, hyperglycemia, metabolic syndrome, hypertension, cardiovascular disease, atherosclerosis, peripheral arterial disease, stroke, heart failure, coronary heart disease, diabetic complications (including but not limited to chronic kidney disease), neuropathy, gastroparesis and other metabolic disorders. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition. |
Author | DUTTAROY, Alokesh LOU, Changgang KANTER, Aaron BRUCE, Alexandra Marshall BARNES, David Weninger IBEBUNJO, Chikwendu KIRMAN, Louise Clare ZECRI, Frederic USERA, Aimee Richardson BOSE, Avirup YAMADA, Ken YUAN, Jun |
Author_xml | – fullname: ZECRI, Frederic – fullname: BARNES, David Weninger – fullname: YUAN, Jun – fullname: LOU, Changgang – fullname: KANTER, Aaron – fullname: USERA, Aimee Richardson – fullname: DUTTAROY, Alokesh – fullname: BRUCE, Alexandra Marshall – fullname: BOSE, Avirup – fullname: KIRMAN, Louise Clare – fullname: YAMADA, Ken – fullname: IBEBUNJO, Chikwendu |
BookMark | eNrjYmDJy89L5WSwcHMMCYlUcHT2dAlWcPRzUQjxcPUMUggNdlXw9FNw9vfzCnV3DPH091MI8Vdw8vT39fdxdQ71cQ3mYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxwe6GBkYGhpaGRpZmpiGOxkQqAwBKziuL |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | SG10201912965TA |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_SG10201912965TA3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:14:40 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_SG10201912965TA3 |
Notes | Application Number: SG20191012965T |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200227&DB=EPODOC&CC=SG&NR=10201912965TA |
ParticipantIDs | epo_espacenet_SG10201912965TA |
PublicationCentury | 2000 |
PublicationDate | 20200227 |
PublicationDateYYYYMMDD | 2020-02-27 |
PublicationDate_xml | – month: 02 year: 2020 text: 20200227 day: 27 |
PublicationDecade | 2020 |
PublicationYear | 2020 |
RelatedCompanies | NOVARTIS AG |
RelatedCompanies_xml | – name: NOVARTIS AG |
Score | 3.2485547 |
Snippet | The invention provides a conjugate comprising a biomolecule linked to a fatty acid via a linker wherein the fatty acid has the following Formula A1:wherein R1,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200227&DB=EPODOC&locale=&CC=SG&NR=10201912965TA |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dT8IwEL8gGvVNUeMXpg9kb4vgxjYeiBldByOwEdYZfCIrK4kPDiIz_vveGvDjRd-atrlcL_n1d732rgANw7BFZppCl6k0dVOmCCl7meqZyKyltWiJlqpbMA6tQWIOZ-1ZBV53uTCqTuiHKo6IiFog3gu1X6-_g1ieelu5uRcv2LV69HnX07an4wdVEU_zel02ibyIapR2474WTtHXRabrILlZbe7uwT560nYJCPbUKxNT1j9ZxT-BgwkKzItTqMi8Bkd09_laDQ7H2ztvbG7htzkDx3c5fyYuDbyYuKFH-IAFU5LEjAQhoVE4TPoq5kR4RHpBNI5GjCYjFp9Dw2ecDnRUYf615Hnc_6WwcQHVfJXLSyBZq2OnjhAl-ZiZ00yb0hGG7UicKtoLeQX1P0Vd_zN-A8elHVXWtn0L1eLtXdaRdwtxp6z1CbckgMc |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NT8IwFH9BNOJNUeMX2gPZbRHc2MaBmNF1bLgPwjqjJ7KyknhwEJnx37drwI-L3pq2eXl9ya-_19e-V4C2ppks13Wm8ozrqs4zASlzkak5y42FMe-yrqxbEEaGl-rjp95TDV63uTCyTuiHLI4oEDUXeC_lfr36DmI58m3l-pa9iK7lvUsHjrI5Hd_JiniKMxyQSezEWMF4kIyUaCp8XcF0fUFuRo_aO7ArvGyzAgR5HFaJKaufrOIewt5ECCzKI6jxogkNvP18rQn74ebOWzQ38Fsfg-XalD4jG_tOguzIQdQj_hSlCUF-hHAcjdORjDkhGqOhH4dxQHAakOQE2i6h2FOFCrOvJc-S0S-FtVOoF8uCnwHKu30zsxiryEfPrU7W4RbTTIuLqaw35-fQ-lPUxT_jN9DwaBjMAj96uISDyqYyg9u8gnr59s5bgoNLdi0t9wntCoO6 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=FATTY+ACIDS+AND+THEIR+USE+IN+CONJUGATION+TO+BIOMOLECULES&rft.inventor=ZECRI%2C+Frederic&rft.inventor=BARNES%2C+David+Weninger&rft.inventor=YUAN%2C+Jun&rft.inventor=LOU%2C+Changgang&rft.inventor=KANTER%2C+Aaron&rft.inventor=USERA%2C+Aimee+Richardson&rft.inventor=DUTTAROY%2C+Alokesh&rft.inventor=BRUCE%2C+Alexandra+Marshall&rft.inventor=BOSE%2C+Avirup&rft.inventor=KIRMAN%2C+Louise+Clare&rft.inventor=YAMADA%2C+Ken&rft.inventor=IBEBUNJO%2C+Chikwendu&rft.date=2020-02-27&rft.externalDBID=A&rft.externalDocID=SG10201912965TA |